Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 209

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma

Open access
Minashi, Keiko, Nihei, Keiji, Mizusawa, Junki, Takizawa, Kohei, Yano, Tomonori, Ezoe, Yasumasa, Tsuchida, Tomohiro, Ono, Hiroyuki, Iizuka, Toshiro, Hanaoka, Noboru, Oda, Ichiro, Morita, Yoshinori, Tajika, Masahiro, Fujiwara, Junko, Yamamoto, Yoshinobu, Katada, Chikatoshi, Hori, Shinichiro, Doyama, Hisashi, Oyama, Tsuneo, Nebiki, Hiroko, Amagai, Kenji, Kubota, Yutaro, Nishimura, Ken, Kobayashi, Nozomu, Suzuki, Takuto, Hirasawa, Kingo, Takeuchi, Toshihisa, Fukuda, Haruhiko, Muto, Manabu·2019·Gastroenterology

Abstract

BACKGROUND & AIMS: Esophagectomy is the standard treatment for stage I esophageal squamous cell carcinoma (ESCC). We conducted a single-arm prospective study to confirm the efficacy and safety of selective chemoradiotherapy (CRT) based on findings from endoscopic resection (ER). METHODS: We performed a prospective study of patients with T1b (SM1-2) N0M0 thoracic ESCC from December 2006 through July 2012; 176 patients underwent ER. Based on the findings from ER, patients received the following: no additional treatment for patients with pT1a tumors with a negative resection margin and no lymphovascular invasion (group A); prophylactic CRT with 41.4 Gy delivered to locoregional lymph nodes for patients with pT1b tumors with a negative resection margin or pT1a tumors with lymphovascular invasion (group B); or definitive CRT (50.4 Gy) with a 9-Gy boost to the primary site for patients with a positive vertical resection margin (group C). Chemotherapy comprised 5-fluorouracil and cisplatin. The primary end point was 3-year overall survival in group B, and the key secondary end point was 3-year overall survival for all patients. If lower limits of 90% confidence intervals for the primary and key secondary end points exceeded the 80% threshold, the efficacy of combined ER and selective CRT was confirmed. RESULTS: Based on the results from pathology analysis, 74, 87, and 15 patients were categorized into groups A, B, and C, respectively. The 3-year overall survival rates were 90.7% for group B (90% confidence interval, 84.0%-94.7%) and 92.6% in all patients (90% confidence interval, 88.5%-95.2%). CONCLUSIONS: In a prospective study of patients with T1b (SM1-2) N0M0 thoracic ESCC, we confirmed the efficacy of the combination of ER and selective CRT. Efficacy is comparable to that of surgery, and the combination of ER and selective CRT should be considered as a minimally invasive treatment option. UMIN-Clinical Trials Registry no.: UMIN000000553.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2019.04.017

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 209

Metadata

Authors
Minashi, K., Nihei, K., Mizusawa, J., Takizawa, K., Yano, T., Ezoe, Y., Tsuchida, T., Ono, H., Iizuka, T., Hanaoka, N., Oda, I., Morita, Y., Tajika, M., Fujiwara, J., Yamamoto, Y., Katada, C., Hori, S., Doyama, H., Oyama, T., Nebiki, H., Amagai, K., Kubota, Y., Nishimura, K., Kobayashi, N., Suzuki, T., Hirasawa, K., Takeuchi, T., Fukuda, H., & Muto, M.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2019-08
Volume
157
Issue
2
Pages
382-390.e3
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2938310871
Cited by
209
References
1
FWCI
23.98
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma. https://app.cochat.ai/papers/10.1053/j.gastro.2019.04.017
The paper
Minashi, K., Nihei, K., Mizusawa, J., Takizawa, K., Yano, T., Ezoe, Y., Tsuchida, T., Ono, H., Iizuka, T., Hanaoka, N., Oda, I., Morita, Y., Tajika, M., Fujiwara, J., Yamamoto, Y., Katada, C., Hori, S., Doyama, H., Oyama, T., . . . Muto, M. (2019). Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma. Gastroenterology. https://doi.org/10.1053/j.gastro.2019.04.017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.